RIPK1 and metabolic dysfunction-associated steatotic liver disease: SENP1 is markedly downregulated in the livers of individuals with NAFLD or NASH and that SENP1 absence from mouse hepatocytes hastens the development of spontaneous NASH-related phenotypes, including liver inflammation, lipid accumulation, liver damage, and fibrosis, in a RIPK1 kinase-dependent manner.